MICAFUNGIN SODIUM

Post-LOE

micafungin sodium

OH Pharmaceutical
ANDAINTRAVENOUSINJECTABLE
Approved
Jul 2021
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

[see Microbiology ()] .

Indications (3)

Acute Disseminated CandidiasisAbscesses in adultolder

Clinical Trials (1)

NCT02678598N/ACompleted

A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections

Started Mar 2015
2,555 enrolled
Invasive Fungal Infections
Company
OP
OH Pharmaceutical
IN - Crown Point
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers